Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Orally active inhibitor of Ras farnesylation reported by Schering-Plough

March 5, 1997

Steroidal antitumor agents described by Taisho

March 5, 1997

Matrix selects distribution partner for Italy

March 5, 1997

TK inhibitors disclosed by Pfizer

March 4, 1997

Takeda describes antitumor agents

March 4, 1997

Novel antitumor agents disclosed by Yale University

March 3, 1997

Kyowa Hakko discloses DC-107 derivatives

March 3, 1997

DepoTech initiates pediatric clinical trial DepoCyt

Feb. 28, 1997

Somatostatin peptides prepared by Novartis

Feb. 28, 1997

Yamanouchi prepares hormonal agents for testosterone-dependent disorders

Feb. 28, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...